ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Oncology letters, 14.2017, issue 5, S. 5443-5451, doi:10.3892/ol.2017.6832
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2017
- Creator
-
Bähr, Oliver
Gross, Stefanie
Harter, Patrick Nikolaus
Kirches, Elmar
Mawrin, Christian
Steinbach, Joachim Peter
Mittelbronn, Michel Guy André
- URN
-
urn:nbn:de:hebis:30:3-450614
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bähr, Oliver
- Gross, Stefanie
- Harter, Patrick Nikolaus
- Kirches, Elmar
- Mawrin, Christian
- Steinbach, Joachim Peter
- Mittelbronn, Michel Guy André
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2017
Other Objects (12)
Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Treatment with a vascular disrupting agent does not increase recruitment of indium labelled human endothelial outgrowth cells in an experimental tumour model
Brain lesions disrupting addiction map to a common human brain circuit
Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism
Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent
Disrupting Education? Experimental Evidence on Technology-Aided Instruction in India
Vascular brain stem diseases
Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism
Disrupting concrete construction
Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Treatment with a vascular disrupting agent does not increase recruitment of indium labelled human endothelial outgrowth cells in an experimental tumour model
Brain lesions disrupting addiction map to a common human brain circuit
Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism
Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent
Disrupting Education? Experimental Evidence on Technology-Aided Instruction in India
Vascular brain stem diseases
Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism
Disrupting concrete construction
Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
Treatment with a vascular disrupting agent does not increase recruitment of indium labelled human endothelial outgrowth cells in an experimental tumour model
Brain lesions disrupting addiction map to a common human brain circuit
Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism
Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent
Disrupting Education? Experimental Evidence on Technology-Aided Instruction in India
Vascular brain stem diseases
Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism